MedTrace Logo

Evaluation of Safety and Efficacy of IPL Presets for Cutaneous Lesions

NCT05630690 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-12-22

No results posted yet for this study

Summary

Single-center, Prospective, Open-Label with Before-After Study Design. Each subject will receive up to three (3) consecutive treatments at 1-month interval. Treatment presets will be determined by the SMART Camera system and approved by the physician. Follow-up will take place at 1 month following the last treatment. Skin and lesion attributes will be examined by the SMART system and the physician on each visit and at follow-up.

Conditions

  • Vascular Lesion
  • Pigmented Lesions

Interventions

DEVICE

IPL with smart diagnostic handpiece

treatment with IPL following diagnostic with SMART system

Sponsors & Collaborators

  • Emek Medical Center

    collaborator OTHER

  • Lumenis Be Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-04
Primary Completion
2024-03-31
Completion
2024-04-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05630690 on ClinicalTrials.gov